MedPath

Samsung Medical Center

Samsung Medical Center logo
🇰🇷South Korea
Ownership
Subsidiary
Established
1994-01-01
Employees
501
Market Cap
-
Website
http://www.samsunghospital.com

The Effect of Online Based Mentoring Program on the Blood Glucose and Satisfaction Score in Type 1 Diabetes Patients

Not Applicable
Completed
Conditions
Type 1 Diabetes
Interventions
Behavioral: Mentoring program
First Posted Date
2010-07-07
Last Posted Date
2015-11-17
Lead Sponsor
Samsung Medical Center
Target Recruit Count
57
Registration Number
NCT01157611
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Gemcitabine/Oxaliplatin (GEMOX) With or Without Erlotinib (Tarceva) in Advanced Biliary Tract Carcinoma

Phase 3
Completed
Conditions
Unresectable, Metastatic Biliary Tract Carcinoma
Interventions
Drug: Gemcitabine/Oxaliplatin with Erlotinib (Tarceva)
Drug: Gemcitabine/Oxaliplatin
First Posted Date
2010-06-23
Last Posted Date
2014-05-15
Lead Sponsor
Samsung Medical Center
Target Recruit Count
266
Registration Number
NCT01149122
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Extent of Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma

Phase 2
Conditions
Carcinoma
Interventions
Procedure: Routine central neck dissection
First Posted Date
2010-06-23
Last Posted Date
2016-04-21
Lead Sponsor
Samsung Medical Center
Target Recruit Count
2000
Registration Number
NCT01149161
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Aromatase (CYP19) Polymorphism Between AI-responsive and AI-resistant Breast Cancer in Korea

Suspended
Conditions
CYP19
Aromatase Inhibitor
Polymorphism
First Posted Date
2010-06-04
Last Posted Date
2014-04-21
Lead Sponsor
Samsung Medical Center
Target Recruit Count
300
Registration Number
NCT01137136
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Lateral Neck Sentinel Lymph Node Biopsy(LSLNB)in PTC

Phase 2
Completed
Conditions
Thyroid Neoplasm
Interventions
Procedure: Lateral sentinel lymph node biopsy
First Posted Date
2010-06-04
Last Posted Date
2016-04-21
Lead Sponsor
Samsung Medical Center
Target Recruit Count
278
Registration Number
NCT01137097
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma

Phase 1
Completed
Conditions
Hepatocellular Carcinoma
First Posted Date
2010-05-27
Last Posted Date
2012-02-02
Lead Sponsor
Samsung Medical Center
Target Recruit Count
20
Registration Number
NCT01131689
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

A Study of Pazopanib With CAPEOX in AGC Patients

Phase 2
Completed
Conditions
Gastric Cancer
Interventions
First Posted Date
2010-05-26
Last Posted Date
2016-04-15
Lead Sponsor
Samsung Medical Center
Target Recruit Count
66
Registration Number
NCT01130805
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC)

Phase 3
Conditions
Non-small Cell Lung Cancer
Interventions
Procedure: stereotactic radiosurgery (SRS)
First Posted Date
2010-05-26
Last Posted Date
2010-05-26
Lead Sponsor
Samsung Medical Center
Target Recruit Count
176
Registration Number
NCT01130766
Locations
🇰🇷

Samsung Medical Center, Seoul,, Korea, Republic of

The Continuation of Erlotinib

Phase 2
Conditions
Non-small Cell Lung Cancer
Interventions
First Posted Date
2010-05-26
Last Posted Date
2010-05-26
Lead Sponsor
Samsung Medical Center
Target Recruit Count
23
Registration Number
NCT01130779
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Efficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Neoplasms
Erlotinib
Neoadjuvant Therapy
First Posted Date
2010-05-26
Last Posted Date
2013-05-30
Lead Sponsor
Samsung Medical Center
Target Recruit Count
43
Registration Number
NCT01130753
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath